Skip to Main Content

Paper Details

Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
J Natl Cancer Inst
3
2023
Early Cancer, Lung cancer, cancer, lung cancer, participants
Author NameAffiliation
Stephanie J WeinsteinNational Cancer Institute
Lesley F TinkerWomen's Health Initiative Clinical Coordinating Center, Fred Hutchinson Cancer Research Center
Rayjean J HungLunenfeld-Tanenbaum Research Institute
Rayjean J HungDalla Lana School of Public Health, University of Toronto
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Xihong LinHarvard T.H. Chan School of Public Health
Xihong LinBroad Institute of Harvard and MIT
Xihong LinHarvard University
Xihong LinHarvard T.H. Chan School of Public Health
Xihong LinBroad Institute of Harvard and MIT
Xihong LinHarvard University
María-José SánchezCentro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP)
María-José Sánchez
María-José SánchezInstituto de Investigacion Biosanitaria ib
María-José SánchezUniversity of Granada
Kristian HveemHUNT Research Centre, Norwegian University of Science and Technology
Roger L Milne
Roger L MilneThe University of Melbourne
Roger L MilneSchool of Clinical Sciences at Monash Health, Monash University
  • 1 - 20

Datasets